Mark A. Wilson

Former Chief Legal OfficeratNektar Therapeutics· In proxies 2021–2025

Pay in FY2022+30% from the year before · Nektar Therapeutics stock -83.3% the same year

Mark A. Wilson was paid $4.6M in FY2022 (Dec), up 30%. Nektar Therapeutics stock fell 83.3% that year.

Pay$100 in the stock at the end of FY20 → $13

Pay is from the Summary Compensation Table of each Nektar Therapeutics proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

Nektar TherapeuticsPublic company · 5 yr
- Former Chief Legal Officer2021 – Present · 5 yrStock in role -86%

Roles come from the proxy statements of each company.

Activity

Pay
Nektar Therapeutics General counsel pay rose 30% to $4.6M. The stock fell 83% in FY2022 (Dec).
DEF 14AApr 26, 2024

For the press:Download CSV Download PNG How to use our data

Two people shown as one, or a wrong number?